Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic testing could bolster radiotherapy’s effectiveness against cancer

06.04.2005


Obtaining a genetic picture of how a tumor will react to the many treatment techniques available could help doctors prescribe therapies customized for individual cancer patients’ needs, suggests a Purdue University research team.



A group of scientists including Jian-Jian "J.J." Li has found a trio of proteins often present in cancer cells that protect the tumor from destruction by radiotherapy. Because no single protein in the group is responsible for keeping the cancer alive, Li said that the key to a successful assault could rest in a deeper understanding of the relationship among these protein molecules – an understanding that could be made available through genetic testing.

"We have discovered that breast cancer cells defend themselves on the molecular level against radiation, and this response could be reducing the effectiveness of modern medicine’s fight against cancer," said Li, who is an associate professor of health sciences in Purdue’s School of Health Sciences. "Because these three proteins interact in ways peculiar to each tumor, it might help doctors to first obtain the ’genetic fingerprint’ of cancerous tissue in order to find out which treatment method will be most effective."


The research appears in this week’s issue of the Journal of Biochemistry. Li’s co-authors include researchers from the City of Hope National Medical Center, Bio-Rad Laboratories and the National Institutes of Health.

All living cells are kept alive through the efforts of thousands of different proteins, each of which may have many different and interrelated functions. Proteins are brought into action, or "expressed," by genes in the cell’s DNA when certain needs arise – such as reproduction or metabolizing energy. Three such proteins found in most human cells have been the focus of Li’s research for several years, each of which is commonly known to scientists by a technical name: ERK, NF-kappa B and GADD45 beta. "In healthy cells, these three proteins all play a role in building new cellular structures, allowing the body to grow and regenerate," Li said. "Each has individual functions that are well known. NF-kappa B and ERK, for example, work as construction managers that tell the genes where more building blocks are needed and how they should be arranged, while GADD45 beta helps repair damage to DNA. This helps keep a cell from mutating as it grows."

NF-kappa B beta is known to be present in abnormally high amounts in tumors. However, scientists also have noticed that after the NF-kappa B has been inhibited, the cancer cells are less responsive to radiotherapy. Apparently, Li said, the presence of the protein keeps tumor cells alive despite receiving a punishing amount of radiation that ordinarily would kill them. "Previous research has also implicated NF-kappa B in this type of radioresistance to cancer," Li said. "No one really knew what was happening. But the issue needed resolution because, once again, we were confronting the standard dilemma in cancer treatment: How do you destroy the cancer without damaging the surrounding healthy cells?"

Li’s group found that it was not just one of these proteins that was fighting hard to save the cells – it was all three. After subjecting breast cancer cells in the lab to the stress of ionizing radiation, the group found that the proteins all are co-activated in a pattern of mutual dependence, coordinating among themselves to increase cell survival rate. "The essence of our discovery can expressed rather simply," Li said. "Genes in the body do not operate in isolation, but as a team. This is the sort of lesson we will probably learn again and again as the recently decoded human genome reveals more of its secrets."

Indeed, it could be in the genome that a solution to the dilemma will be found, Li said. "If we can test cancer cells not for just three proteins but for thousands, the ’genetic fingerprint’ such a test would provide might help us to devise better therapies to kill tumors," he said. "Knowing in general that proteins A, B and C are defending the cell may allow us to administer drugs that block them, which could allow us to irradiate the now-defenseless cancer with lower radiation levels. This would be simultaneously more effective against the cancer and less harmful to the patient in general."

In the case of breast cancer cells, the proteins in question are ERK, NF-kappa B and GADD45 beta. But Li said that this was probably the first of many discoveries that relate proteins to one another in such a fashion. "These three proteins are most likely the tip of the iceberg," Li said. "This discovery is all about interaction, which goes beyond any one protein or gene expression. People used to think NF-kappa B was just a gene regulator. Now we realize it could be part of a signaling network that decides the pattern of gene expression – a pattern that remains mysterious."

This research was funded in part by the National Institutes of Health’s National Cancer Institute and the Department of Energy.

Li is associated with the Purdue Cancer Center. One of just eight National Cancer Institute-designated basic-research facilities in the United States, the center attempts to help cancer patients by identifying new molecular targets and designing future agents and drugs for effectively detecting and treating cancer.

Writer: Chad Boutin, (765) 494-2081, cboutin@purdue.edu

Source: Jian-Jian Li, jjli@purdue.edu

Purdue News Service: (765) 494-2096; purduenews@purdue.edu

Chad Boutin | EurekAlert!
Further information:
http://www.purdue.edu

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>